Vomiting, or emesis, is a protective reflex designed to expel toxic substances from the body. However, this reflex can also be triggered by medications, metabolic disorders, and vestibular stimulation. The physiological process is coordinated by the vomiting center located in the medulla oblongata of the brainstem. This center receives direct and indirect signals from several anatomical areas.
Antiemetic drugs are categorized based on the specific neurotransmitter receptors they block in the emetic pathway. Selecting the correct class depends heavily on identifying the underlying cause of the vomiting.
| Drug Class | Primary Target Receptor | Main Clinical Indication |
|---|---|---|
| 5-HT3 Antagonists | Serotonin (5-HT3) | Chemotherapy-induced and postoperative nausea |
| Dopamine Antagonists | Dopamine (D2) | Gastroenteritis, general nausea, and migraines |
| NK1 Antagonists | Substance P / NK1 | Delayed chemotherapy-induced nausea |
| Antihistamines | Histamine (H1) | Motion sickness and vertigo |
| Anticholinergics | Muscarinic (M1) | Motion sickness and vestibular conditions |
Drugs like ondansetron and granisetron are the gold standard for preventing acute chemotherapy-induced, radiation-induced, and postoperative nausea and vomiting. They work by blocking serotonin receptors centrally in the chemoreceptor trigger zone and peripherally on vagal nerve terminals in the intestines.
Because they lack the sedative and extrapyramidal side effects common to older antiemetics, they are well-tolerated by patients of all ages. However, nurses must monitor patients for QT prolongation, a cardiac conduction abnormality that can lead to dangerous dysrhythmias like torsades de pointes. Other mild adverse effects include headache and constipation.
Dopamine receptor antagonists, including phenothiazines like promethazine and prochlorperazine, as well as benzamides like metoclopramide, act primarily by blocking D2 receptors in the chemoreceptor trigger zone. They are effective against nausea caused by metabolic disorders, toxins, and gastroenteritis.
Clinical use requires vigilance due to notable adverse reactions. Blocking dopamine in the central nervous system can trigger extrapyramidal symptoms, such as involuntary muscle spasms, akathisia, and tardive dyskinesia. Phenothiazines also cause significant sedation and carry a risk of severe tissue necrosis if extravasation occurs during intravenous administration.
Management of highly emetogenic chemotherapy regimens requires combination therapy because acute and delayed nausea involve different neural pathways. Aprepitant and its intravenous prodrug fosaprepitant are NK1 receptor antagonists that cross the blood-brain barrier to block substance P in the brain, effectively preventing delayed emetic responses.
Corticosteroids, most commonly dexamethasone, are powerful adjuncts in antiemetic therapy. While their exact mechanism of action in emesis remains partially unclear, they enhance the efficacy of 5-HT3 and NK1 antagonists. Combining an NK1 antagonist, a 5-HT3 antagonist, and dexamethasone forms the baseline prophylactic regimen for highly emetogenic cancer treatments.
The inner ear houses the vestibular system, which controls balance and spatial orientation. Overstimulation of this apparatus during travel sends neural impulses via the vestibular nerve and acetylcholine pathways directly to the vomiting center. Antihistamines (such as dimenhydrinate and meclizine) and anticholinergics (such as scopolamine) interrupt these signals.
Scopolamine is often administered as a transdermal patch placed behind the ear. These agents cause prominent anticholinergic side effects, including dry mouth, blurred vision, urinary retention, and drowsiness. Nurses should caution patients against operating heavy machinery or performing tasks requiring high alertness until they know how the medication affects them.
Comprehensive nursing care requires thorough assessment before and after administering antiemetics. The nurse must document the exact frequency, duration, and characteristics of the emetic episodes, as well as any triggers. Assessing baseline hydration status is vital, checking for dry mucous membranes, poor skin turgor, sunken eyes, and decreased urine output.
Electrolyte imbalances—particularly hypokalemia and metabolic alkalosis—frequently accompany prolonged vomiting due to the loss of gastric hydrochloric acid and potassium. Nurses should monitor serum electrolyte panels, assess vital signs for orthostatic hypotension, and evaluate the effectiveness of the prescribed antiemetic regimen regularly.
Safe administration of antiemetics requires an understanding of patient-specific contraindications and potential drug interactions. For instance, prokinetic agents like metoclopramide are contraindicated in patients with mechanical bowel obstruction or gastrointestinal hemorrhage because increased peristalsis could cause perforation.
Patients should be educated on managing minor side effects, such as taking oral antiemetics with food if they cause gastric upset, or rising slowly from a sitting position to prevent dizziness. Nurses must instruct patients to report severe side effects immediately, including muscle spasms, chest pain, palpitations, or inability to urinate.